Ulrich Mrowietz

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Ulrich Mrowietz, Knud Kragballe, Kristian Reich et al. · Archives of Dermatological Research · 2010 · 868 citations · Full text

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Delano Pathirana, AD Ormerod, P. Saïag et al. · Journal of the European Academy of Dermatology and Venereology · 2009 · 695 citations · Full text

Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Jens‐Michael Schröder, Ulrich Mrowietz, Eishin Morita et al. · The Journal of Immunology · 1987 · 534 citations · Full text

Quality of life of patients with keloid and hypertrophic scarring

Oliver Bock, Gerhard Schmid‐Ott, Peter Malewski et al. · Archives of Dermatological Research · 2006 · 497 citations

Hypertrophic Scarring, Surgical Pathology, Scar Prevention +5

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

C. Paul, Jennifer Clay Cather, Melinda Gooderham et al. · British Journal of Dermatology · 2015 · 464 citations · Full text